- Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. [A phase I trial. 8/16 patients had recurrence free survival for 18 months, the current duration of the trial] https://www.nature.com/articles/s41586-023-06063-y 5 comments futurology
Linking pages
- Pancreatic Cancer Vaccine Shows Promise in Small Trial - The New York Times https://www.nytimes.com/2023/05/10/health/pancreatic-cancer-vaccine-mrna.html 174 comments
- New Cancer Vaccines Could Treat Some Types of Pancreatic, Colorectal and Other Deadly Forms of the Disease | Scientific American https://www.scientificamerican.com/article/new-cancer-vaccines-could-treat-some-types-of-pancreatic-colorectal-and-other-deadly-forms-of-the-disease/ 18 comments
- Pancreatic Cancer Vaccine Shows Promise in Small Initial Trial - Scientific American https://www.scientificamerican.com/article/pancreatic-cancer-vaccine-shows-promise-in-small-initial-trial/ 16 comments
- These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It https://www.inverse.com/health/vaccines-heart-disease-cancer-mrna 6 comments
Related searches:
Search whole site: site:www.nature.com
Search title: Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer | Nature
See how to search.